Navigation Links
Linden Capital Partners Completes Acquisition of Young Innovations, Inc.
Date:1/31/2013

ST. LOUIS, Jan. 31, 2013  /PRNewswire/ -- Young Innovations, Inc. ("Young" or the "Company") today announced the completion of its acquisition by affiliates of Linden Capital Partners ("Linden") in an all-cash transaction valued at approximately $314 million.

As previously announced, the transaction was approved by Young shareholders at a special meeting of shareholders held January 30, 2013. Pursuant to the terms of the agreement and plan of merger, Young's shareholders are entitled to receive $39.50 in cash, without interest, less any applicable withholding taxes, for each share of Young common stock owned by them. As a result of the acquisition, Young's common stock will no longer be listed for trading on NASDAQ.

Shareholders of record will receive a letter of transmittal and instructions on how to surrender their shares of Young common stock in exchange for the merger consideration. Shareholders of record should wait to receive the letter of transmittal before surrendering their shares.

Robert W. Baird & Co. Incorporated served as financial advisor, and provided a fairness opinion, to the Board of Directors of Young in connection with the transaction. McDermott Will & Emery LLP served as legal advisors to Young in connection with the transaction. Kirkland & Ellis LLP served as legal counsel to Linden in connection with the transaction.

About Young Innovations, Inc.:

Young develops, manufactures and markets supplies and equipment used by dentists, dental hygienists, dental assistants and consumers. The Company's consumables product offering includes disposable and metal prophy angles, prophy cups and brushes, dental micro-applicators, moisture control products, infection control products, dental handpieces (drills) and related components, endodontic systems, orthodontic toothbrushes, flavored examination gloves, children's toothbrushes, and chil
'/>"/>

SOURCE Young Innovations, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Young Innovations Announces Definitive Agreement to be Acquired by Linden Capital Partners
2. CytoSorbents Receives Approximately $400,000 in Non-Dilutive Capital from the Sale of Net Operating Loss Carryovers
3. Foundation Venture Capital Group Invests In Start-Up Working to Reduce Side Effects of Parkinsons Treatment
4. Proposed Regulatory Uniformity to Boost Venture Capital Investments in Healthcare Arena, Says Frost & Sullivan
5. Topokine Therapeutics Secures Financing from Schooner Capital to Advance Clinical Development of XAF5 Gel
6. American Capital Receives $60 Million From The Sale Of Lifoam Holdings And Generates An 11% Return On Its Investment
7. BioScrip To Present At "NINE" Noble Financial Capital Markets Ninth Annual Equity Conference
8. OncoSec Medical to Present at Noble Financial Capital Markets Ninth Annual Equity Conference on January 22
9. Unisense FertiliTech A/S Secures 24 Million USD in New Capital Investment
10. Kerry R. Hicks Joins Physicians Capital Investments as Vice-Chairman of Board
11. DePuy Settlement Funding And Transvaginal Mesh Capital Increased At Legal-Bay
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... SALT LAKE CITY , Aug. 28, 2014 /PRNewswire-iReach/ ... in 2000 by service academy graduates, has published a ... its concentrated, three-day Leadership Excellence Course . In ... the  Leadership Excellence Course to Albuquerque , ... Tucson . Photo - http://photos.prnewswire.com/prnh/20140828/140814 ...
(Date:8/28/2014)... , August 28, 2014 ... "DNA diagnostics Market (products, applications, techniques, end users ... Growth and Forecast, 2013 - 2020," indicates that ... billion by 2020 registering a CAGR of 9.8% ... accurate diagnosis and cost effectiveness over alternative diagnostic ...
(Date:8/28/2014)... , Aug. 28, 2014   Venaxis, Inc. ... focused on obtaining FDA clearance for and commercializing its ... test for aiding in identifying children, adolescent, and young ... low risk for appendicitis, today announced it will present ... 16 th Annual Global Investment Conference being held ...
Breaking Medicine Technology:Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 3Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 4Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 5DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3Venaxis to Present at September Investor Conferences 2Venaxis to Present at September Investor Conferences 3
... Model of Diabetes with Haptoglobin 2-2 Genotype Show, ... Transport, MONTVALE, N.J., March 31 Synvista,Therapeutics, ... a study of diabetic mice,with the Haptoglobin 2-2 ... Haptoglobin (Hp)-Hemoglobin (Hb) complex may result in a ...
... is now enrolling ... patients, ... announced today the start of a Phase III clinical trial,studying LY450139, an ... LY450139 is being tested,to see if it can slow the progression associated ...
Cached Medicine Technology:Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions 2Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions 3Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions 4Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease 2Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease 3Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease 4Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease 5Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease 6
(Date:8/28/2014)... did the earliest birds take wing? Did they fall from ... Or did they run along the ground and pump their ... million years in the past, but a new University of ... birds have an innate ability to maneuver in midair, a ... rather than fall from a perch. , The study looked ...
(Date:8/28/2014)... NJ Top Docs Presents Dr. Christophe Oliveira ... Top Doc, Dr. Christophe Oliveira, has just announced ... for the department of transportation. Dr. Oliveira has ... all drug testing for commercial drivers. , Having ... disorders including disk herniations, spinal stenosis, muscle sprains/strains, ...
(Date:8/28/2014)... (BRONX, NY) Researchers from Albert Einstein College of ... a potential antibody therapy for Sudan ebolavirus (SUDV), one of ... the Zaire ebolavirus (EBOV), is now devastating West Africa. First ... (most recently in 2012) that have killed more than ... ACS Chemical Biology . , Between 30 and 90 ...
(Date:8/28/2014)... In 2012, The Ben & Catherine Ivy Foundation ... brain cancer research projects at the Translational Genomics ... officially received the final regulatory approval from University ... for the trial can begin. , In the ... Trial," TGen and its clinical partners will lead ...
(Date:8/28/2014)... A herbal preparation prescribed by a Chinese herbal ... in life-threatening heart changes, prompting a team of ... appropriate patient education by practitioners who prescribe complementary ... , the journal of the Australasian College for ... and Dr Nicky Dobos from the Intensive Care ...
Breaking Medicine News(10 mins):Health News:Flapping baby birds give clues to origin of flight 2Health News:Flapping baby birds give clues to origin of flight 3Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 2Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 3Health News:Drug shows promise against Sudan strain of Ebola in mice 2Health News:TGen receives approval for patient enrollment in brain cancer clinical trial 2Health News:Deadly remedy: Warning issued about Chinese herbal medicine 2
... Bulgaria’s Agriculture Minister Nihat Kabil has revealed that ... bird flu. The bird was however not infected ... dangerous H5 virus. The dead swan was found ... was unable to say whether avian flu had ...
... expected in poultry during the course of 2006, according to ... take place // among human beings on a large scale, ... Governments have however been called upon to be prepared ... have been called upon to improve their surveillance where the ...
... end up losing as many as over 200 doctors, over the ... abortion. // The Catholic doctors who are from Queensland are of ... be deprived of his powers when it comes to deciding upon ... ,The AMA on the other hand is calling for ...
... meeting with Boston Scientific to talk about the repairs in ... held in 2001 with Schering-Plough // about problems with its ... to make any amendments. This provoked the FDA to withhold ... solve this problem Raul E. Cesan, the company's president and ...
... of the Teratology Society published a paper in the journal ... ,In this paper they said that overweight and ... develop medical problems at birth. ,This paper talked ... obese mothers. , It is stated that they ...
... closely monitored surveillance for patients with colon and rectal ... recurrence // compared to less aggressive strategy which is ... found that an intensified follow up of patients in ... diagnosis of cancer recurrence which could help in treatment ...
Cached Medicine News:
For the quantitative determination of alkaline phosphatase in human serum....
... of low density lipoprotein cholesterol ... Liquid stable, ready-to-use reagent. Selective ... measurement. Excellent correlation with established ... substances. Available with Calibrator: Trucal ...
Storage temperature: 2 - 8C, linearity: 0 - 25 mg/dL, expected value: male: 3.5 - 7.0 mg/dL and female: 2.5 - 6.0 mg/dL. Available with calibrator and number of test 500....
The assay kit is for determination of uric acid in serum or urine. Wavelength: 600 nm. Linear range: up to 80 mg/dL....
Medicine Products: